Want to see HK:8217 full AI Analyst Report?
8217 Stock Chart & Stats
HK$0.38
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.38
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.08 - HK$0.41
Previous CloseN/A
Volume100.00K
Average Volume (3M)973.87K
Market Cap
HK$32.60M
Enterprise ValueHK$60.90M
Total Cash (Recent Filing)HK$54.16M
Total Debt (Recent Filing)HK$12.00M
Price to Earnings (P/E)1.4
Beta0.15
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding301,860,000
10 Day Avg. Volume383,125
30 Day Avg. Volume973,865
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.73
Price to Sales (P/S)2.33
P/FCF Ratio11.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved LeverageLower leverage materially reduces balance-sheet strain and increases financial flexibility. With debt roughly stable and equity rising in 2026, the company can better withstand project delays, support bidding capacity, and access financing at lower cost if operating performance stabilises.
Return To Positive Cash FlowA return to positive operating and free cash flow signals improved cash-generation ability versus prior years. If sustained, this reduces reliance on external funding, supports working-capital needs for project execution, and provides scope for selective reinvestment or deleveraging over the medium term.
Revenue ReboundA 15% revenue rebound indicates recovering demand and the potential to scale fixed-costs in future periods. Sustained top-line growth provides the opportunity to improve operating leverage and margin conversion over time, assuming the company can translate higher revenue into durable operating profits.
Bears Say
Persistent Operating LossesCore operations remain unprofitable with very thin gross margins, indicating structural margin pressure in the business model. Persistent operating losses mean the company depends on non-operating items to report net profits, putting long-term sustainability and ability to self-fund growth at risk.
Earnings Quality RiskA headline net profit driven by likely non-recurring items undermines confidence in reported earnings and future distributable cash. This disconnect complicates forecasting, may not improve credit metrics sustainably, and limits management's room to commit to dividends or long-term investments.
Volatile Cash Flow & RevenueSignificant year-to-year swings in cash flow and revenue suggest sensitivity to project timing and working-capital cycles typical in construction. This volatility raises financing and execution risk, makes budgeting harder, and can force opportunistic balance-sheet actions during troughs.
8217 FAQ
What was Luen Wong Group Holdings Ltd.’s price range in the past 12 months?
Luen Wong Group Holdings Ltd. lowest stock price was HK$0.07 and its highest was HK$0.41 in the past 12 months.
What is Luen Wong Group Holdings Ltd.’s market cap?
Luen Wong Group Holdings Ltd.’s market cap is HK$32.60M.
When is Luen Wong Group Holdings Ltd.’s upcoming earnings report date?
Luen Wong Group Holdings Ltd.’s upcoming earnings report date is Nov 17, 2026 which is in 100 days.
How were Luen Wong Group Holdings Ltd.’s earnings last quarter?
Luen Wong Group Holdings Ltd. released its earnings results on Jun 30, 2026. The company reported HK$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.006.
Is Luen Wong Group Holdings Ltd. overvalued?
According to Wall Street analysts Luen Wong Group Holdings Ltd.’s price is currently Overvalued.
Does Luen Wong Group Holdings Ltd. pay dividends?
Luen Wong Group Holdings Ltd. does not currently pay dividends.
What is Luen Wong Group Holdings Ltd.’s EPS estimate?
Luen Wong Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Luen Wong Group Holdings Ltd. have?
Luen Wong Group Holdings Ltd. has 301,860,000 shares outstanding.
What happened to Luen Wong Group Holdings Ltd.’s price movement after its last earnings report?
Luen Wong Group Holdings Ltd. reported an EPS of HK$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.077%.
Which hedge fund is a major shareholder of Luen Wong Group Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8217
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Luen Wong Group Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.24%
Trailing 12-Months
Company Description
Luen Wong Group Holdings Ltd.
"As an investment holding company, Ju Fu Tang Biotech Holdings Co., Ltd primarily delivers a comprehensive range of civil engineering, decoration, and renovation services across Hong Kong. Its extensive portfolio covers infrastructure development, specifically road and drainage systems. This encompasses the building and enhancement of local roads and carriageway junctions, along with related facilities such as footpaths, planting zones, drainage networks, sewer lines, water mains, and utility relocation solutions. Additionally, the company undertakes foundational structural projects, including the erection of reinforced concrete structures for bridges and retaining walls. Furthermore, their expertise extends to site preparation, involving excavation and filling operations essential for new site development or future construction. The entity previously operated under the name WMHW Holdings Limited before rebranding as Ju Fu Tang Biotech Holdings Co., Ltd in September 2025. Established in 2015, the firm maintains its headquarters in Causeway Bay, Hong Kong."
Technical Analysis
Kwong Luen Engineering Holdings Limited
―
New Concepts Holdings Ltd
―
Steve Leung Design Group Limited
―
Sam Woo Construction Group Ltd.
―
K W Nelson Interior Design and Contracting Group Limited
―